Suzuki, Y.; Katayama, Y.; Fujimoto, Y.; Toyoda, K.; Takahashi, M.; Tamano, M.
Effect of Concomitant Use of Polaprezinc and Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication. Gastroenterol. Insights 2024, 15, 386-395.
https://doi.org/10.3390/gastroent15020027
AMA Style
Suzuki Y, Katayama Y, Fujimoto Y, Toyoda K, Takahashi M, Tamano M.
Effect of Concomitant Use of Polaprezinc and Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication. Gastroenterology Insights. 2024; 15(2):386-395.
https://doi.org/10.3390/gastroent15020027
Chicago/Turabian Style
Suzuki, Yuto, Yasumi Katayama, Yo Fujimoto, Koji Toyoda, Morio Takahashi, and Masaya Tamano.
2024. "Effect of Concomitant Use of Polaprezinc and Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication" Gastroenterology Insights 15, no. 2: 386-395.
https://doi.org/10.3390/gastroent15020027
APA Style
Suzuki, Y., Katayama, Y., Fujimoto, Y., Toyoda, K., Takahashi, M., & Tamano, M.
(2024). Effect of Concomitant Use of Polaprezinc and Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication. Gastroenterology Insights, 15(2), 386-395.
https://doi.org/10.3390/gastroent15020027
